Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Korea, /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a ...

New kit system enables selection of granule sizes suited for patient anatomy in real time BonVie+ is a calcium-salt ...

The Global Craniomaxillofacial Implants Market was valued at approximately USD 1.49 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of over 6.40% from 2024 to ...

In this final PMA module, Instylla has submitted clinical study resultsto the FDA, advancing our pursuit of the indication ...

LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-F,' a resorbable microsphere for musculoskeletal pain embolization, has received the Breakthrough ...

NEXTBIOMEDICAL CO., LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-Ftm,' a resorbable microsphere for musculoskeletal pain embolization, has ...

Atreon Orthopedics, LLC, a Columbus based innovator in tissue healing and regenerative technologies, has received 510(k) clearance from the Food and Drug Administration (FDA) to expand the use of ...

LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-F™,' a resorbable microsphere for musculoskeletal pain embolization, has received the ...